|
Lally M, Goldsworthy R, Sarr M, Kahn J, Brown L, Peralta L, Zimet G.
"Evaluation of an Intervention Among Adolescents to Reduce Preventive Misconception in HIV Vaccine Clinical Trials." Journal of Adolescent Health, vol. 55, no. 2, 2014, pp. 254-9.
|
|
Ma M, Kibler JL, Vigil-Otero A, Sarpong D, Lally M, Mayer KH.
"Correlates of willingness to participate in microbicide research among African Americans." Journal of Health Psychology, vol. 18, no. 1, 2013, pp. 65-74.
|
|
Hosek SG, Green KR, Siberry G, Lally M, Balthazar C, Serrano PA, Kapogiannis B, The Adolescent Medicine Trials Network for HIV/AIDS Interventions.
"Integrating Behavioral HIV Interventions into Biomedical Prevention Trials with Youth: Lessons from Chicago's Project PrEPare." Journal of HIV/AIDS & Social Services, vol. 12, no. 3-4, 2013.
|
|
Ott MA, Alexander AB, Lally M, Steever JB, Zimet GD, Adolescent Medicine Trials Network (ATN) for HIV/AIDS Interventions.
"Preventive misconception and adolescents' knowledge about HIV vaccine trials." Journal of Medical Ethics, vol. 39, no. 12, 2013, pp. 765-71.
|
|
Hosek SG, Siberry G, Bell M, Lally M, Kapogiannis B, Green K, Fernandez MI, Rutledge B, Martinez J, Garofalo R, Wilson CM, Adolescent Trials Network for HIVAIDS Interventions (ATN).
"The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men." Journal of Acquired Immune Deficiency Syndrome, vol. 62, no. 4, 2013, pp. 447-56.
|
|
Nunn, Amy, Cornwall, Alexandra, Chute, Nora, Sanders, Julia, Thomas, Gladys, James, George, Lally, Michelle, Trooskin, Stacey, Flanigan, Timothy.
"Keeping the Faith: African American Faith Leaders’ Perspectives and Recommendations for Reducing Racial Disparities in HIV/AIDS Infection." PLoS ONE, vol. 7, no. 5, 2012, pp. e36172.
|
|
Li M, Aliotta JM, Asara JM, Tucker L, Quesenberry P, Lally M, Ramratnam B.
"Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic cells." PROTEOMICS, vol. 12, no. 13, 2012, pp. 2203-11.
|
|
Churchyard GJ, Morgan C, Adams E, Hural J, Graham BS, Moodie Z, Grove D, Gray G, Bekker LG, McElrath MJ, Tomaras GD, Goepfert P, Kalams S, Baden LR, Lally M, Dolin R, Blattner W, Kalichman A, Figueroa JP, Pape J, Schechter M, Defawe O, De Rosa SC, Montefiori DC, Nabel GJ, Corey L, Keefer MC, NIAID HIV Vaccine Trials Network.
"A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)." PLoS ONE, vol. 6, no. 8, 2011, pp. e21225.
|
|
Spearman P, Lally MA, Elizaga M, Montefiori D, Tomaras GD, McElrath MJ, Hural J, De Rosa SC, Sato A, Huang Y, Frey SE, Sato P, Donnelly J, Barnett S, Corey LJ, HIV Vaccine Trials Network of NIAID.
"A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers." The Journal of Infectious Diseases, vol. 203, no. 8, 2011, pp. 1165-73.
|
|
Nugent NR, Lally MA, Brown L, Knopik VS, McGeary JE.
"OPRM1 and Diagnosis-Related Posttraumatic Stress Disorder in Binge-Drinking Patients Living with HIV." AIDS and Behavior, vol. 16, no. 8, 2011, pp. 2171-80.
|
|
Rudy BJ, Kapogiannis BG, Lally MA, Gray GE, Bekker LG, Krogstad P, McGowan I.
"Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials." Journal of Acquired Immune Deficiency Syndrome, vol. 54 Suppl 1, 2010, pp. S31-42.
|
|
Harro CD, Robertson MN, Lally MA, O'Neill LD, Edupuganti S, Goepfert PA, Mulligan MJ, Priddy FH, Dubey SA, Kierstead LS, Sun X, Casimiro DR, DiNubile MJ, Shiver JW, Leavitt RY, Mehrotra DV, Merck V520-007/012 Study Teams.
"Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults." AIDS Research and Human Retroviruses, vol. 25, no. 1, 2009, pp. 103-14.
|
|
Lally MA, Montstream-Quas SA, Tanaka S, Tedeschi SK, Morrow KM.
"A qualitative study among injection drug using women in Rhode Island: attitudes toward testing, treatment, and vaccination for hepatitis and HIV." AIDS Patient Care and STDs, vol. 22, no. 1, 2008, pp. 53-64.
|
|
Quirk EK, Mogg R, Brown DD, Lally MA, Mehrotra DV, DiNubile MJ, Robertson MN.
"HIV seroconversion without infection after receipt of adenovirus-vectored HIV type 1 vaccine." Clinical Infectious Diseases, vol. 47, no. 12, 2008, pp. 1593-9.
|
|
Priddy FH, Brown D, Kublin J, Monahan K, Wright DP, Lalezari J, Santiago S, Marmor M, Lally M, Novak RM, Brown SJ, Kulkarni P, Dubey SA, Kierstead LS, Casimiro DR, Mogg R, DiNubile MJ, Shiver JW, Leavitt RY, Robertson MN, Mehrotra DV, Quirk E, Merck V520-016 Study Group.
"Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults." Clinical Infectious Diseases, vol. 46, no. 11, 2008, pp. 1769-81.
|
|
Beckwith CG, Atunah-Jay S, Cohen J, Macalino G, Poshkus M, Rich JD, Flanigan TP, Lally MA.
"Feasibility and acceptability of rapid HIV testing in jail." AIDS Patient Care and STDs, vol. 21, no. 1, 2007, pp. 41-7.
|
|
Beckwith CG, Cohen J, Shannon C, Raz L, Rich JD, Lally MA.
"HIV testing experiences among male and female inmates in Rhode Island." The AIDS reader, vol. 17, no. 9, 2007, pp. 459-64.
|
|
Lally M, Gaitanis M, Vallabhaneni S, Reinert S, Mayer K, Zimet G, Rich J.
"Willingness to receive an HIV vaccine among incarcerated persons." Preventive Medicine, vol. 43, no. 5, 2006, pp. 402-5.
|
|
Lally MA, MacNevin R, Sergie Z, Hitt R, DiSpigno M, Cenedella C, Stein MD.
"A model to provide comprehensive testing for HIV, viral hepatitis, and sexually transmitted infections at a short-term drug treatment center." AIDS Patient Care and STDs, vol. 19, no. 5, 2005, pp. 298-305.
|
|
De Groot AS, Bishop EA, Khan B, Lally M, Marcon L, Franco J, Mayer KH, Carpenter CC, Martin W.
"Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine." Methods, vol. 34, no. 4, 2004, pp. 476-87.
|
|
Pugatch DL, Levesque BG, Lally MA, Reinert SE, Filippone WJ, Combs CM, Flanigan TP, Brown LK.
"HIV testing among young adults and older adolescents in the setting of acute substance abuse treatment." Journal of Acquired Immune Deficiency Syndrome, vol. 27, no. 2, 2001, pp. 135-42.
|
|
Pugatch D, Levesque B, Greene S, Strong L, Flanigan T, Lally M.
"HIV testing in the setting of inpatient acute substance abuse treatment." American Journal of Drug and Alcohol Abuse, vol. 27, no. 3, 2001, pp. 491-9.
|
|
Farley JL, Mitty JA, Lally MA, Burzynski JN, Tashima K, Rich JD, Cu-Uvin S, Spaulding A, Normandie L, Snead M, Flanigan TP.
"Comprehensive medical care among HIV-positive incarcerated women: the Rhode Island experience." Journal of Women's Health and Gender Based Medicine, vol. 9, no. 1, 2000, pp. 51-6.
|
|
Mylonakis E, Paliou M, Lally M, Flanigan TP, Rich JD.
"Laboratory testing for infection with the human immunodeficiency virus: established and novel approaches." The American Journal of Medicine, vol. 109, no. 7, 2000, pp. 568-76.
|
Brown AIDS Center (CFAR)
Health Services, Policy and Practice
